Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Inventory (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Inventory for 7 consecutive years, with $15.4 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 1.23% to $15.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.4 million through Dec 2025, up 1.23% year-over-year, with the annual reading at $15.4 million for FY2025, 1.23% up from the prior year.
  • Inventory hit $15.4 million in Q4 2025 for Eton Pharmaceuticals, down from $16.9 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $23.8 million in Q2 2025 to a low of $334000.0 in Q3 2021.
  • Historically, Inventory has averaged $5.0 million across 5 years, with a median of $1.1 million in 2021.
  • Biggest five-year swings in Inventory: tumbled 80.34% in 2021 and later skyrocketed 1572.01% in 2024.
  • Year by year, Inventory stood at $550000.0 in 2021, then increased by 1.27% to $557000.0 in 2022, then surged by 63.55% to $911000.0 in 2023, then surged by 1572.01% to $15.2 million in 2024, then increased by 1.23% to $15.4 million in 2025.
  • Business Quant data shows Inventory for ETON at $15.4 million in Q4 2025, $16.9 million in Q3 2025, and $23.8 million in Q2 2025.